サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1588342

脳震とうの市場規模、シェア、動向分析レポート：評価・治療別、最終用途別、地域別、セグメント別予測、2025年～2030年

Concussion Market Size, Share & Trends Analysis Report By Assessment And Treatment (Diagnosis, Treatment), By End Use (Hospitals, Diagnostic Centers) By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
脳震とうの市場規模、シェア、動向分析レポート：評価・治療別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2024年10月23日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳震とう市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の脳震とうの市場規模は2025年から2030年にかけてCAGR 6.0%で拡大し、2030年には93億1,000万米ドルに達すると予測されています。

脳震とうのような関連障害の高い有病率につながる脳に引き起こされる傷害の数が増加していることが、市場を積極的に牽引しています。

転倒やスポーツ外傷に続いて自動車事故が脳震とう患者の入院の主な原因となっています。米国疾病予防管理センター（CDC）によると、転倒事故による軽度の頭部損傷（脳震とう）の結果、毎年推定56,000人の高齢者が入院しています。これが予測期間中の市場成長を押し上げると予想されます。

さらに、脳震とうに関連する意識を高めるためのいくつかの啓発キャンペーンやイニシアチブが世界中で実施されていることも、市場成長の総体的な要因となっています。例えば、Defense and Veterans Brain Injury Centerは、軍人や退役軍人のための最善のケアを促進するために、外傷性脳損傷について学ぶためのオンライン教育を民間人と軍人の両方に提供しています。

さらに、主要企業は市場シェアを拡大するため、提携や新製品の発売などさまざまな戦略を採用しています。これが予測期間中の市場成長を後押しするとみられます。例えば、2019年には日本光電が米国で、意識不明の患者の脳活動を評価することを目的としたワイヤレス脳波（EEG）ヘッドセットを発売しました。

脳震とう市場レポートハイライト

  • 診断分野が市場を独占し、2024年には72.2%の最大収益シェアを占めました。診断分野は、診断技術の進歩や脳震とうの発生率の増加により、今後数年で大きく成長すると予測されます。
  • 病院分野は、脳震とう関連のリスクに対する意識の高まりと、高度な診断・治療ソリューションの提供に対する病院のコミットメントによって、2024年に39.1%の最大市場シェアを占めました。
  • 北米の脳震とう市場は世界市場全体を支配し、2024年の売上シェアの60.9%を占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 脳震とう市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • 脳震とう市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 脳震とう市場：評価・治療の推定・動向分析

  • セグメントダッシュボード
  • 脳震とう市場：評価・治療変動分析
  • 評価・治療別脳震とう市場の見通し
  • 2018年から2030年までの市場規模と予測および動向分析
  • 治療
  • 診断

第5章 脳震とう市場： 最終用途の推定・動向分析

  • セグメントダッシュボード
  • 脳震とう市場：最終用途の変動分析
  • 最終用途別脳震とう市場の見通し
  • 2018年から2030年までの市場規模と予測および動向分析
  • 病院
  • 診断センター
  • 神経科クリニック
  • 研究センター
  • その他

第6章 脳震とう市場：地域の推定・動向分析

  • 地域ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年：
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 市場参入企業の分類
  • 主要市場参入企業による最近の動向と影響分析
  • 企業市場シェア分析、2024年
  • 主要企業プロファイル
    • NIHON KOHDEN CORPORATION
    • Compumedics Limited
    • INTEGRA LIFESCIENCES
    • BioDirection（NanoDx）
    • Oculogica
    • Abbott
    • BrainScope Company Inc.
    • BIOMERIEUX
    • Magstim
    • Advanced Brain Monitoring, Inc.
    • Healius Limited
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America concussion market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 4 North America concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 6 U.S. concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 8 Canada concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 10 Mexico concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe concussion market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 13 Europe concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Germany concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 15 Germany concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 17 UK concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 18 France concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 19 France concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Italy concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 21 Italy concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Spain concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 23 Spain concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Denmark concussion market, by assessment and treatment, (USD Million)
  • Table 25 Denmark concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Sweden concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 27 Sweden concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Norway concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific concussion market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 34 China concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Japan concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 36 Japan concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 37 India concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 38 India concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 40 South Korea concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Australia concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 42 Australia concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Thailand concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 44 Thailand concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 46 Latin America concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Brazil concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 48 Brazil concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Argentina concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 50 Argentina concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 51 MEA concussion market, by region, 2018 - 2030 (USD Million)
  • Table 52 MEA concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 53 MEA concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 54 South Africa concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 55 South Africa concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 58 UAE concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 59 UAE concussion market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait concussion market, by assessment and treatment, 2018 - 2030 (USD Million)
  • Table 61 Kuwait concussion market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Concussion market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based size & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot (global and regional)
  • Fig. 8 Assessment and treatment segment and end use segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Magnetic resonance imaging and concussion market, value, 2024 (USD Billion)
  • Fig. 11 Market dynamics
  • Fig. 12 Traumatic brain injury statistics per year, U.S.
  • Fig. 13 Serious injuries due to road accidents by country in 2024
  • Fig. 14 Sports product-related injuries in the U.S. in 2022 & 2023
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 PESTLE analysis
  • Fig. 17 Concussion market: Assessment and treatment outlook and key takeaways
  • Fig. 18 Concussion market: Assessment and treatment movement analysis
  • Fig. 19 Diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Computed tomography (CT) scan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Magnetic resonance imaging (MRI) devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Electroencephalography (EEG) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Concussion market: End use outlook and key takeaways
  • Fig. 26 Concussion market: End use movement analysis
  • Fig. 27 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Diagnostic centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Neurologic clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Research centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Concussion market revenue by region, 2024 & 2030, (USD Million)
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 North America concussion market, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 U.S. concussion market, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Canada concussion market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe concussion market, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 UK concussion market, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Germany concussion market, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 France concussion market, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Italy concussion market, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Spain concussion market, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Sweden concussion market, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Denmark concussion market, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Norway concussion market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific concussion market, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Japan concussion market, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 China concussion market, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 India concussion market, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Australia concussion market, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 South Korea concussion market, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Thailand concussion market, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America concussion market, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Brazil concussion market, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Mexico concussion market, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Argentina concussion market, 2018 - 2030 (USD Million)
  • Fig. 77 Middle East & Africa concussion market, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Africa concussion market, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Saudi Arabia concussion market, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 UAE concussion market, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Kuwait concussion market, 2018 - 2030 (USD Million)
  • Fig. 86 Key company categorization
  • Fig. 87 Concussion market share analysis, 2024
  • Fig. 88 Strategic framework
目次
Product Code: GVR-4-68039-154-2

Concussion Market Growth & Trends:

The global concussion market size is anticipated to reach USD 9.31 billion by 2030, expanding at a CAGR of 6.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing number of injuries being caused to the brain resulting in a high prevalence of associated disorders such as concussion is driving the market in a positive manner.

Falls and sports injuries followed by motor vehicle accidents are the leading causes of hospitalization in patients with concussion. As per the Centers for Disease Control and Prevention (CDC), an estimated 56,000 seniors are hospitalized every year as a result of mild head injuries (concussions) suffered due to accidental falls. This is anticipated to boost market growth over the forecast period.

In addition, several awareness campaigns and initiatives throughout the world to raise awareness related to concussion are collectively responsible for market growth. For instance, the Defense and Veterans Brain Injury Center offers online education for both civilians and military officers to learn about traumatic brain injuries in order to promote the best possible care for service members and veterans.

Furthermore, key players are adopting various strategies such as collaborations and new product launches to increase their market share. This is likely to boost market growth during the forecast period. For instance, in 2019, Nihon Kohden launched a wireless Electroencephalogram (EEG) headset in the U.S, which is intended to assess brain activity in unconscious patients.

Concussion Market Report Highlights:

  • The diagnosis segment dominated the market and accounted for the largest revenue share of 72.2% in 2024. The diagnosis segment is projected to experience substantial growth in the coming years, driven by advancements in diagnostic technologies and an increasing incidence of concussions.
  • The hospital segment accounted for the largest market share of 39.1% in 2024, driven by growing awareness of concussion-related risks and hospitals' commitment to delivering advanced diagnostic and treatment solutions.
  • The concussion market in North America dominated the overall global market and accounted for 60.9% of revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Assessment and treatment
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Concussion Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing incidence of mild traumatic brain injuries or concussions
      • 3.2.1.2. Rising number of road accidents and sports injuries
      • 3.2.1.3. Technological advancements in concussion devices
      • 3.2.1.4. Growing focus on research activities
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with concussion treatment
      • 3.2.2.2. Lack of awareness in people regarding concussion
  • 3.3. Concussion Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Concussion Market: Assessment and Treatment Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Concussion Market: Assessment and Treatment Movement Analysis
  • 4.3. Concussion Market by Assessment and Treatment Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Treatment
    • 4.5.1. Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Diagnosis
    • 4.6.1. Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Concussion Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Concussion Market: End Use Movement Analysis
  • 5.3. Concussion Market by End Use Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Hospitals
    • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Diagnostic Centers
    • 5.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Neurologic Clinics
    • 5.7.1. Neurologic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Research centers
    • 5.8.1. Neurologic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Concussion Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Recent Developments & Impact Analysis by Key Market Participants
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Key Company Profiles
    • 7.4.1. NIHON KOHDEN CORPORATION
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Compumedics Limited
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. INTEGRA LIFESCIENCES
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. BioDirection (NanoDx)
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Oculogica
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Abbott
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. BrainScope Company Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. BIOMERIEUX
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Magstim
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Advanced Brain Monitoring, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Healius Limited
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives